Search Results - "Gaya, Daniel R."

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults by Lamb, Christopher Andrew, Kennedy, Nicholas A, Raine, Tim, Hendy, Philip Anthony, Smith, Philip J, Limdi, Jimmy K, Hayee, Bu'Hussain, Lomer, Miranda C E, Parkes, Gareth C, Selinger, Christian, Barrett, Kevin J, Davies, R Justin, Bennett, Cathy, Gittens, Stuart, Dunlop, Malcolm G, Faiz, Omar, Fraser, Aileen, Garrick, Vikki, Johnston, Paul D, Parkes, Miles, Sanderson, Jeremy, Terry, Helen, Gaya, Daniel R, Iqbal, Tariq H, Taylor, Stuart A, Smith, Melissa, Brookes, Matthew, Hansen, Richard, Hawthorne, A Barney

“…Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal…”
Get more information

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic by Kennedy, Nicholas A, Jones, Gareth-Rhys, Lamb, Christopher A, Appleby, Richard, Arnott, Ian, Beattie, R Mark, Bloom, Stuart, Brooks, Alenka J, Cooney, Rachel, Dart, Robin J, Edwards, Cathryn, Fraser, Aileen, Gaya, Daniel R, Ghosh, Subrata, Greveson, Kay, Hansen, Richard, Hart, Ailsa, Hawthorne, A Barney, Hayee, Bu'Hussain, Limdi, Jimmy K, Murray, Charles D, Parkes, Gareth C, Parkes, Miles, Patel, Kamal, Pollok, Richard C, Powell, Nick, Probert, Chris S, Raine, Tim, Sebastian, Shaji, Selinger, Christian, Smith, Philip J, Stansfield, Catherine, Younge, Lisa, Lindsay, James O, Irving, Peter M, Lees, Charlie W

“…The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from…”
Get more information

Can molecular stratification improve the treatment of inflammatory bowel disease? by Wang, Claire, Baer, Hannah M., Gaya, Daniel R., Nibbs, Robert J.B., Milling, Simon

“…[Display omitted] Inflammatory bowel disease (IBD) is a debilitating chronic inflammatory disease of the gastrointestinal (GI) tract. It affects more than 3.5…”
Get full text

Utility of faecal calprotectin analysis in adult inflammatory bowel disease by Smith, Lyn A, Gaya, Daniel R

“…The inflammatory bowel diseases （IBD）, Crohn＇s disease and ulcerative colitis, are chronic relapsing, remitting disorders. Diagnosis, along with assessment of…”
Get full text

The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease by Wright, Pamela B., McDonald, Elizabeth, Bravo-Blas, Alberto, Baer, Hannah M., Heawood, Anna, Bain, Calum C., Mowat, Allan M., Clay, Slater L., Robertson, Elaine V., Morton, Fraser, Nijjar, Jagtar Singh, Ijaz, Umer Z., Milling, Simon W. F., Gaya, Daniel R.

“…To understand the contribution of mononuclear phagocytes (MNP), which include monocyte-derived intestinal macrophages, to the pathogenesis of inflammatory…”
Get full text

The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred by Ijaz, Umer Zeeshan, Quince, Christopher, Hanske, Laura, Loman, Nick, Calus, Szymon T, Bertz, Martin, Edwards, Christine A, Gaya, Daniel R, Hansen, Richard, McGrogan, Paraic, Russell, Richard K, Gerasimidis, Konstantinos

“…Studying the gut microbiota in unaffected relatives of people with Crohn's disease (CD) may advance our understanding of the role of bacteria in disease…”
Get full text

Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease by Steell, Lewis, Gray, Stuart R, Russell, Richard K, MacDonald, Jonathan, Seenan, John Paul, Wong, Sze Choong, Gaya, Daniel R

“…Musculoskeletal deficits are among the most commonly reported extra-intestinal manifestations and complications of inflammatory bowel disease (IBD), especially…”
Get full text

Catastrophic gastrointestinal complication of systemic immunosuppression by Smith, Lyn Alexandra, Gangopadhyay, Mitali, Gaya, Daniel R

“…We present a case of acute upper gastrointestinal haemorrhage in a patient with systemic vasculitis immunosuppressed on cyclophosphamide and prednisolone.The…”
Get full text

Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) by Hanna, Catherine R, O'Cathail, Sean M, Graham, Janet S, Saunders, Mark, Samuel, Leslie, Harrison, Mark, Devlin, Lynsey, Edwards, Joanne, Gaya, Daniel R, Kelly, Caroline A, Lewsley, Liz-Anne, Maka, Noori, Morrison, Paula, Dinnett, Louise, Dillon, Susan, Gourlay, Jacqueline, Platt, Jonathan J, Thomson, Fiona, Adams, Richard A, Roxburgh, Campbell S D

“…Advances in multi-modality treatment of locally advanced rectal cancer (LARC) have resulted in low local recurrence rates, but around 30% of patients will…”
Get full text

Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study by Peyrin-Biroulet, Laurent, Van Assche, Gert, Sturm, Andreas, Gisbert, Javier P, Gaya, Daniel R, Bokemeyer, Bern, Mantzaris, Gerassimos J, Armuzzi, Alessandro, Sebastian, Shaji, Lara, Nuria, Lynam, Mark, Rojas-Farreras, Sonia, Fan, Tao, Ding, Qian, Black, Christopher M, Kachroo, Sumesh

“…Abstract Background Ulcerative colitis (UC) is a life time disease and issues with therapy may impact on patient satisfaction and treatment preferences. Aims…”
Get full text

Long-Term Skeletal Disproportion in Childhood-Onset Crohn's Disease by Mason, Avril, Gerasimidis, Konstantinos, Iljuhhina, Jelena, Laird, Susan, Munro, Joanne, Gaya, Daniel R, Russell, Richard K, Ahmed, S Faisal

“…It is unclear whether Crohn's disease (CD) is associated with skeletal disproportion in adulthood. Height (Ht), sitting height (SHt) and leg length were…”
Get more information

A multicentre Study of Nutrition Risk Assessment in Adult Patients with Inflammatory Bowel Disease Attending Outpatient Clinics by Lomer, Miranda C E, Cahill, Orla, Baschali, Aristea, Partha Sarathy, Prasanna, Sarantidou, Magda, Mantzaris, Gerassimos J, Gaya, Daniel R, Katsanos, Konstantinos, Christodoulou, Dimitrios K, Gerasimidis, Konstantinos

“…Overnutrition and undernutrition can affect patients with inflammatory bowel disease (IBD). Although all IBD outpatients should be screened for nutrition risk,…”
Get more information

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) by Hanna, Catherine R, O'Cathail, Sean M, Graham, Janet S, Saunders, Mark, Samuel, Leslie, Harrison, Mark, Devlin, Lynsey, Edwards, Joanne, Gaya, Daniel R, Kelly, Caroline A, Lewsley, Liz-Anne, Maka, Noori, Morrison, Paula, Dinnett, Louise, Dillon, Susan, Gourlay, Jacqueline, Platt, Jonathan J, Thomson, Fiona, Adams, Richard A, Roxburgh, Campbell S D

Get full text

Treatment of Active Crohn’s Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition by Svolos, Vaios, Hansen, Richard, Nichols, Ben, Quince, Christopher, Ijaz, Umer Z., Papadopoulou, Rodanthi T., Edwards, Christine A., Watson, David, Alghamdi, Adel, Brejnrod, Asker, Ansalone, Cecilia, Duncan, Hazel, Gervais, Lisa, Tayler, Rachel, Salmond, Jonathan, Bolognini, Daniele, Klopfleisch, Robert, Gaya, Daniel R., Milling, Simon, Russell, Richard K., Gerasimidis, Konstantinos

“…Exclusive enteral nutrition (EEN) is the only established dietary treatment for Crohn's disease (CD), but its acceptability is limited. There is a need for…”
Get full text

Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease—new insights into dietary disease triggers by Logan, Michael, Gkikas, Konstantinos, Svolos, Vaios, Nichols, Ben, Milling, Simon, Gaya, Daniel R., Seenan, John Paul, Macdonald, Jonathan, Hansen, Richard, Ijaz, Umer Z., Russell, Richard K., Gerasimidis, Konstantinos

“…Summary Background Exclusive enteral nutrition (EEN) is an effective treatment for Crohn's disease. Aims To investigate the hypothesis that ingredients of EEN…”
Get full text

A prospective analysis of micronutrient status in quiescent inflammatory bowel disease by MacMaster, Morag Jane, Damianopoulou, Spyridoula, Thomson, Christina, Talwar, Dinesh, Stefanowicz, Fiona, Catchpole, Anthony, Gerasimidis, Konstantinos, Gaya, Daniel R.

“…ESPEN guidelines advocate patients with inflammatory bowel disease (IBD) have their micronutrient levels checked regularly. This study described the…”
Get full text

Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom by Lim, Samuel Hsiang, Gros, Beatriz, Sharma, Esha, Lehmann, Anouk, Lindsay, James O, Caulfield, Louise, Gaya, Daniel R, Taylor, Jo, Limdi, Jimmy, Kwok, Jon, Shuttleworth, Elinor, Dhar, Anjan, Burdge, Gemma, Selinger, Christian, Cococcia, Sara, Murray, Charles, Balendran, Karthiha, Raine, Tim, George, Becky, Walker, Gareth, Aldridge, Robin, Irving, Peter, Lees, Charlie W, Samaan, Mark

“…Abstract Background and Aims Despite intravenous (IV) vedolizumab being established for treatment of inflammatory bowel disease (IBD), the novel subcutaneous…”
Get full text

UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care by Brooks, Alenka J, Smith, Philip J, Cohen, Richard, Collins, Paul, Douds, Andrew, Forbes, Valda, Gaya, Daniel R, Johnston, Brian T, McKiernan, Patrick J, Murray, Charles D, Sebastian, Shaji, Smith, Monica, Whitley, Lisa, Williams, Lesley, Russell, Richard K, McCartney, Sara A, Lindsay, James O

“…The risks of poor transition include delayed and inappropriate transfer that can result in disengagement with healthcare. Structured transition care can…”
Get more information

Benefits of Structured Pediatric to Adult Transition in Inflammatory Bowel Disease: The TRANSIT Observational Study by McCartney, Sara, Lindsay, James O., Russell, Richard K., Gaya, Daniel R., Shaw, Ian, Murray, Charlie D., Finney-Hayward, Tricia, Sebastian, Shaji

“…To evaluate the impact of structured transition from pediatric to adult inflammatory bowel disease (IBD) services on objective patient outcomes, including…”
Get full text

Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST by Peyrin‐Biroulet, Laurent, Vermeire, Séverine, D'Haens, Geert, Panés, Julian, Dignass, Axel, Magro, Fernando, Nazar, Maciej, Le Bars, Manuela, Lahaye, Marjolein, Ni, Lioudmila, Bravatà, Ivana, Lavie, Frederic, Daperno, Marco, Lukáš, Milan, Armuzzi, Alessandro, Löwenberg, Mark, Gaya, Daniel R., Danese, Silvio

“…Summary Background STARDUST, a phase 3b randomised trial, compared ustekinumab therapeutic strategies in patients with Crohn's disease (CD) using early…”
Get full text